Alkermes plc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Alkermes plc (ALKS) current stock price?
As of the latest data, Alkermes plc stock price is $34.91, with a previous close of $33.55. Alkermes plc gained $1.36 in the last trading session, representing a 4.05% increase.
What is Alkermes plc (ALKS) current market capitalization?
Alkermes plc market cap is approximately 5.76 billion.
What is Alkermes plc (ALKS) Earnings Per Share (EPS)?
The trailing EPS is $2.01, and the forward EPS is $2.03.
What is Alkermes plc (ALKS) Price-to-Earnings (P/E) ratio?
Alkermes plc current P/E ratio is 17.37, with a forward P/E of 17.2.
What is Alkermes plc (ALKS) EBITDA?
Alkermes plc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 108.83 million.
Does Alkermes plc (ALKS) pay dividends?
No. Alkermes plc does not pay a dividend.
How did Alkermes plc (ALKS) perform in its most recent earnings report?
In the last report (September 30, 2025), Alkermes plc posted an EPS surprise of 71.26% and a revenue surprise of 10.66%.
When is Alkermes plc (ALKS) next earnings report?
Alkermes plc is expected to release its next earnings report on December 31, 2025.
What is Alkermes plc (ALKS) beta (volatility) score?
Alkermes plc has a beta of 0.429, indicating lower volatility than the overall market.